Fruit Street Health
OperatingFruit Street Health, P.B.C.
Biotech · New York, NY · Founded 2014
High-Quality Telemedicine Services & Software
Financials
FY2018–FY2019 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Fundraising history
Team
4 people
Laurence Girard is the CEO and Founder of Fruit Street Health, which offers the only diabetes prevention program (DPP) delivered via live video conferencing with Registered Dietitians and manages COVID.MD. Laurence is a telehealth innovator and has been working in the healthcare space since 2011. He is also an alumni of the Kairos Society, a global network of social entrepreneurs focused on having a social impact. Laurence received his Bachelor of Liberal Arts at the Harvard Extension School. He is also a Managing Director of Hippocrates VC and an owner of the New Amsterdam Football Club. Fruit Street is Laurence's primary job and he works there 40 hours a week.
As the CTO of Fruit Street Health, Ian McFarland brings more than 30 years of experience as an entrepreneur and technologist. Prior to joining the company, he served as the CTO and Co-Founder of Pearl Therapeutics, which develops and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. As a veteran in the technology industry, he also held various leadership positions for companies like Friendster, WIRED Magazine, Pivotal Labs and DIgital Garage and has served as a speaker at industry events including SxSW, Lean Startup Conference and JavaOne.
Dr Sharma is Board Certified in Family Medicine. His mission is to provide his patients with improved health, quality of life, daily activity level, and to help his patients achieve their personal goals through careful follow up, ongoing physical therapy, tools for personal growth, and delivery of high quality medical care. Dr. Sharma is licensed in Colorado, Utah, Washington, Oregon, Idaho, Ohio, New Mexico, Texas, South Carolina, & Nevada. His professional vision is to develop resources with other like minded physicians and health care providers to promote positive impacts in healthcare delivery in his community as well as regionally and beyond. His personal passion is to support, develop, and assist other individuals in achieving continuously successful results through leadership guidance and mentorship. Dr. Sharma works part-time for Fruit Street Health.
Physician executive and a practicing emergency physician at HEPA. Board certified in emergency medicine and internal medicine. Strong interest in entrepreneurship and healthcare IT startups. Specialties: Emergency Department management, Efficiency, Patient satisfaction, Patient Safety, Electronic Medical Records, Technology in medicine, Drones, Healthcare startups, Utilization, Provider education, Risk management, Leadership development, Community Hospitals, Urgent care, Emergency care.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 18 filings on EDGAR- Form DMar 7, 20250001609428-25-000001EDGAR
- Form DSep 30, 20240001609428-24-000001EDGAR
- Form D/ASep 28, 20230001609428-23-000001EDGAR
- Form D/AJan 7, 20210001609428-21-000002EDGAR
- Form DJan 7, 20210001609428-21-000001EDGAR
- Form D/ADec 31, 20200001609428-20-000002EDGAR
- Form C-WJun 16, 20200001665160-20-000826EDGAR
- Form C/AJun 2, 20200001665160-20-000695EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.